Scientists In Vietnam Try To Prolong API Of Roche's Tamiflu For H1N1
This article was originally published in PharmAsia News
Executive Summary
Vietnam researchers are trying to find a way to prolong the effectiveness of about 10 million doses of Roche's Tamiflu (oseltamivir) left over from the earlier H1N1 flu pandemic